The Singapore Exchange’s Nifty futures traded 104.5 points, or 0.58 percent, higher at 18,165, indicating that Dalal Street will have a good Tuesday.
The top stocks that will be the focus of today’s focus are listed below:
Larsen & Toubro: Due to improved project execution in the infrastructure projects sector and ongoing growth momentum in the IT and TS portfolio, L&T’s consolidated PAT increased by 22.5% to Rs 2,229 crore while consolidated revenue increased by 23% to Rs 42,763 crore. At the group level, the company received orders totaling Rs 51,914 crore during the quarter, representing a 23% year-over-year increase. As of the end of September, the group’s total order book was worth Rs 372,381 crore.
Tata Steel: Due to rising expenses, Tata Steel’s consolidated net profit for the July-September quarter of 2022–23 fell by over 90% to Rs 1,297 crore. In the comparable period of the prior financial year, the company’s net profit totaled Rs 12,547.70 crore. In comparison to the same time a year prior, its total revenue from July through September 2022 was Rs 60,206.78 crore versus Rs 60,657.98 crore. The company’s overall costs increased from Rs 47,239.63 crore to Rs 57,684.09 crore.
Bharti Airtel: Thanks to substantial growth in data traffic, the telecom company’s consolidated net profit for Q2FY23 increased 89% to Rs 2,145.2 crore from Rs 1,134 crore recorded a year ago. The earnings matched analysts’ expectations. Its overall revenue was Rs 34,526.8 crore, an increase of 22% over the Rs 28,326.4 crore reported in the same period last year.
Glenmark Pharmaceuticals: Fingolimod capsules, 0.5 mg, a generic form of Gilenya1 Capsules, 0.5 mg, from Novartis Pharmaceuticals Corporation, were released by Glenmark Pharmaceuticals Inc (USA). Gilenya Capsules, 0.5 mg had yearly sales of almost $1.8 billion for the 12-month period ending September 2022, according to IQVIA sales statistics.
Equitas Small Finance Bank: The small finance bank’s profit for the three months ending in September FY23 was Rs 116 crore, up 183% year over year. At Rs 610 crore, net interest income for Q2FY23 climbed 26% year over year. As of September FY23, gross advances were Rs 22,779 crore, up 20% YoY, while disbursements were Rs 3,845 crore, up 22% YoY.
Data Patterns: The company’s PAT increased by 63% to Rs 21 crore, while its EBITDA increased by 47% as a result of lower operating costs. To Rs 90 crore, the overall revenue increased by 51%. The company has orders in hand worth Rs 884 crore.
GHCL: The company reported that its net profit increased by 212% year over year to Rs 289 crore from Rs 93 crore the previous year. The inorganic chemicals business, whose revenue increased by 98% year over year to Rs 1,130 crore, helped drive the standalone revenue up 73% to Rs 1,389 crore. EBITDA increased by 159% year over year to Rs 442 crore.